221/697US=9 / Urologia
Aragon-Ching JB, Dahut W. Investigational angiogenesis inhibitors. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 225-32. ISBN 978-1-60327-831-7.

INIBIDORES DA ANGIOGENESE; ANTIANGIOGENESIS; ENSAIOS CLINICOS; CANCER DE PROSTATA; TIROSINA QUINASES

222/697US=9 / Urologia
Keller ET, Hall CL. Pathophysiology of prostate cancer bone metastasis. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 245-54. ISBN 978-1-60327-831-7.

FISIOPATOLOGIA DA PROSTATA; METASTASE OSSEA DO CANCER; CANCER DE PROSTATA; METASTASE OSSEA; RANKL; PROTEINA MORFOGENETICA OSSEA

223/697US=9 / Urologia
Sartor O, Venugopal DR. Radiopharmaceuticals. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 255-66. ISBN 978-1-60327-831-7.

RADIOFARMACOS; SAMARIO-EDTMP; CLORETO DE ESTRONCIO; RADIO; FOSFORO; PALIACAO; CANCER DE PROSTATA; METASTASES OSSEAS; TERAPIA OSSO-ALVO

224/697US=9 / Urologia
Saylor PJ, Smith MR. Bisphosnates for prevention and treatment of bone metastases. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 267-75. ISBN 978-1-60327-831-7.

CANCER DE PROSTATA; METASTASES OSSEAS; ODANACATIB; OSTEOCLASTOS; BISFOSFONATO; ESQUELETICOS RELACIONADOS COM EVENTOS; DENOSUMAB

225/697US=9 / Urologia
Nelson JB. Endothelin receptors as therapeutic targets in castration-resistant prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 277-86. ISBN 978-1-60327-831-7.

RECEPTORES DE ENDOTELINA; CASTRACAO CANCER DE PROSTATA. TERAPIAS; METASTASES OSSEAS; ENSAIOS CLINICOS; RECEPTORES DE ENDOTELINA; ENDOTELINA-1; CANCER DE PROSTATA

226/697US=9 / Urologia
Madan RA, Gulley JL, Celestin J, Arlen PM, Schlom J. Cancer immunology, immunotherapeutics, and vaccine approaches. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 305-19. ISBN 978-1-60327-831-7.

CANCER DE IMUNOLOGIA; IMUNOTERAPIA; VACINA DO CANCER; CANCER DE PROSTATA

227/697US=9 / Urologia
Higano CS. Sipuleucel-T: autologous cellular immunotherapy for metastatic castration-resistant prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 321-27. ISBN 978-1-60327-831-7.

SIPULEUCEL-T; IMUNOTERAPIA CELULAR AUTOLOGA; CANCER DE PROSTATA; METASTATICO RESISTENTE A CASTRACAO; HORMONIO REFRATARIO; PROVENCE; IMUNOTERAPIA CELULAR AUTOLOGA; RESISTENTE A CASTRACAO; APC8015

228/697US=9 / Urologia
Patel LR, Simons JW. GM-CSF gene-transduced prostate cancer vaccines: GVAX. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 329-42. ISBN 978-1-60327-831-7.

GM-CSF; GVAX; VACINAS; CANCER DE PROSTATA; IMUNOTERAPIA

229/697US=9 / Urologia
Parnes HL, House MG, Tanfrea JA. Prostate cancer chemoprevention strategies. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 351-62. ISBN 978-1-60327-831-7.

QUIMIOPREVENCAO DO CANCER DE PROSTATA; QUIMIOPREVENCAO; DESENVOLVIMENTO DE AGENTES; DESFECHOS DO ESTUDO; COORTES; PCPT; REDUCE

230/697US=9 / Urologia
Chan JM, Richman EL. Diet and prostate cancer incidence, recurrence, and progression risk. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 363-73. ISBN 978-1-60327-831-7.

DIETA; NUTRICAO; CANCER DE PROSTATA

231/697US=9 / Urologia
Lucia MS, Lambert JR, Platz EA, Marzo AM. Inflammation as a target in prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 375-86. ISBN 978-1-60327-831-7.

INFLAMACAO; CANCER DE PROSTATA; CARCINOGENESE; QUIMIOPREVENCAO; QUIMIOTERAPIA; CITOCINAS; INFLAMACAO; ESTRESSE OXIDATIVO

232/697US=9 / Urologia
Alva AS, Bradley DA, Hussain M. Challenges for the development of new agents in prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 389-97. ISBN 978-1-60327-831-7.

CANCER DE PROSTATA; NOVOS AGENTES DIRECIONADOS; DESAFIOS; DESENVOLVIMENTO DE MEDICAMENTOS

233/697US=9 / Urologia
Ning YM, Dagher RN, Pazdur R. FDA approval of prostate cancer treatments. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 399-405. ISBN 978-1-60327-831-7.

FDA DOS TRATAMENTOS DO CANCER DE PROSTATA; APROVACAO DE MEDICAMENTOS; DESENVOLVIMENTO DE MEDICAMENTOS; ENDPOINTS; FDA; ANALISE POST-HOC; CANCER DE PROSTATA; ANALISE DE SUBGRUPO; PARAMETROS DE SUBSTITUICAO; SOBREVIVENCIA

234/697US=9 / Urologia
Gross M, Nepomuceno EM, Agus DB. Applications of proteomics in prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 407-17. ISBN 978-1-60327-831-7.

PROTEOMICA; CANCER DE PROSTATA; ESPECTROMETRIA DE MASSA; BIOMARCADOR; ANTIGENO PROSTATICO ESPECIFICO; IMUNO-HISTOQUIMICA

235/697US=1-A / Farmacologia
Chabner BA, Amrein PC, Druker BJ, Michaelson MD, Mitsiades CS, Goss PE, Ryan DP, Ramachandra S, Richardson PG, Supko JG, Wilson WH. Agentes antineoplásicos. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1185-264. ISBN 85-6330801-6.

CANCER. TRATAMENTO FARMACOLOGICO; AGENTES QUIMIOTERAPICOS; AGENTES ALQUILANTES; COMPLEXOS DE COORDENACAO DA PLATINA; ANTIMETABOLITOS; ACIDO FOLICO; ANALOGOS DA PIRIMIDINA; ANALOGOS DA CITIDINA; ANALOGOS DAS PURINAS; PRODUTOS NATURAIS; AGENTES ANTIMITOTICOS; ANALOGOS DA CAMPTOTECINA; ANTIBIOTICOS; EPIPODOFILOTOXINAS; BLEOMICINA; MITOMICINA; ENZIMAS; ASPARAGINASE; HIDROXIUREIA; RETINOIDE; TRIOXIDO DE ARSENICO; INIBIDORES DA PROTEINA TIROSINOCINASE; IMATINIBE; GEFITINIBE; ERLOTINIBE; TALIDOMIDA; ESTRAMUSTINA; BORTEZOMIBE; ACIDO ZOLEDRONICO; MITOTANO; MODIFICADORES DA RESPOSTA BIOLOGICA; INTERLEUCINA; ANTICORPOS MONOCLONAIS; RITUXIMABE; ALENTUZUMABE; TRASTUZUMABE; CETUXIMABE; BEVACIZUMABE; GENTUZUMABE; RADIOIMUNOCONJUGADOS; IMUNOTOXINA; GLICOCORTICOIDES; PROGESTINA; ESTROGENIO; ANDROGENIO; INIBIDORES DA AROMATASE; CANCER DE PROSTATA. TERAPIA ANTIANDROGENICA

236/697US=26-A / Radioterapia
Lee AK, Pollack A. The prostate. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 676-729. ISBN 978-0-323-04971-9.

PROSTATA; CANCER DE PROSTATA; RADIOTERAPIA; TECNICAS RADIOTERAPICAS; BRAQUITERAPIA; PROSTATECTOMIA; CRIOTERAPIA

237/697US=3-I / Patologia
Epstein JI. The lower urinary tract and male genital system. In: Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran pathologic basis of disease. 8ª ed. Philadelphia: Saunders Elsevier, 2010. p. 971-1004. ISBN 978-0-4160-3121-5.

TRATO URINARIO INFERIOR; SISTEMA GENITAL MASCULINO; URETER. ANOMALIAS CONGENITAS; URETRITE; BEXIGA. ANOMALIAS CONGENITAS; CANCER DE BEXIGA; OBSTRUCAO DA BEXIGA; URETRA; CANCER DE URETRA; PENIS. ANOMALIAS CONGENITAS; CANCER DE PENIS; TESTICULO; EPIDIDIMO; CRIPTOCHIDISMO; ATROFIA; ORCHITE GRANULOMATOSA; TORCAO TESTICULAR; CANCER DE TESTICULOS; PROSTATA; PROSTATITE; HIPERPLASIA BENIGNA DA PROSTATA; CANCER DE PROSTATA; ADENOCARCINOMA DA PROSTATA

238/697US=5 / Biol/Mol
Emmenegger U, Francia G, Shaked Y, Kerbel RS. Metronomic chemotherapy: principles and lessons learned from applications in the treatment of metastatic prostate cancer. In: Liersch R, Berdel WE, Kessler T. Angiogenesis inhibition. New York: Springer, 2010. p. 165-83. (Recent results in cancer research) ISBN 978-3-540-78280-3.

QUIMIOTERAPIA METRONOMICA; CANCER DE PROSTATA METASTATICO

239/697US=6 / Ortopedia
Peyruchaud O, Karin NJ. Lysophosphatidic acid: role in bone and bone cancer. In: Bronner F, Farac-Carson MC. Bone and cancer. New York: Springer-Verlag, 2009. p. 73-88. (Topics in bone biology) ISBN 978-1-84882-018-0.

ACIDO LISOFOSFATIDICO (LPA); CANCER OSSEO; ATIVIDADES BIOLOGICAS DA LPA; RECEPTORES DA LPA; EFEITOS DA LPA NAS CELULAS ESQUELETICAS; FUNCOES REGULADORAS DA LPA; CANCER METASTATICO DO OSSO; CANCER DE TIREOIDE; CANCER DE PROSTATA; CANCER DE MAMA

240/697US=6 / Ortopedia
Chung LWK, Zhau HE, Petros JA, Farach-Carson MC. Prostate cancer bone colonization: osteomimicry in the bone niche. In: Bronner F, Farac-Carson MC. Bone and cancer. New York: Springer-Verlag, 2009. p. 157-66. (Topics in bone biology) ISBN 978-1-84882-018-0.

CANCER OSSEO; CANCER DE PROSTATA; OSTEOMIMICRY; NICHO OSSEO; ALTERACOES FENOTIPICAS; RANKL; OSTEOCLASTOGENESE

Primeira | Anterior | Próxima | Última